AI Breakthrough in Breast Cancer Screening: Detecting High Risk in Women Given All-Clear

A groundbreaking Australian-made AI tool has been developed to detect high breast cancer risk in women who were previously given a clean bill of health, revolutionizing breast cancer screening and potentially saving lives.

TL;DR
• The AI tool can detect high breast cancer risk in women given all-clear, improving screening accuracy and reducing wait times.
• The tool uses machine learning to analyze mammograms and provide a personalized risk score.
• Researchers believe the tool could be rolled out in five years, potentially saving thousands of lives.

Summary
An Australian-made artificial intelligence tool has shown the ability to detect women with a high likelihood of breast cancer who were otherwise missed in normal screening. The AI tool, called BRAIx, was developed using data from nearly half a million mammograms of Australian women and an independent dataset of around 4,500 women in Sweden. It provides a personalized risk score between 0 and 99.9 that predicts a woman's likelihood of having breast cancer at any time over the next four years. The study found one in 10 women who were in the top 2 per cent of risk scores went on to develop breast cancer, even though their mammograms were all clear.

The AI tool identified women that were at the same or greater risk of breast cancer as those with the deadly BRCA gene mutations. It was more accurate than current methods for determining risk, such as age and family history. The tool could support the Australian radiology workforce, which is experiencing shortages amid growing demand from an aging population.

Key insights include:
• The AI tool can estimate a woman's risk of developing breast cancer more accurately than other methods doctors rely on.
• The tool provides a personalized risk score that predicts the woman's likelihood of having breast cancer at any time over the next four years.
• The AI tool identified women that were at the same or greater risk of breast cancer as those with the deadly BRCA gene mutations.
• The researchers believe the tool will be ready to roll out in the next five years.

The AI tool is particularly good at identifying those with the most elevated risk levels. Women determined by the tool as being in the top 2 per cent of risk had the same or greater likelihood of developing cancer than women with BRCA1 and BRCA2 gene mutations. The research is a game changer, according to Adelaide University breast health researcher Wendy Ingman, who was not involved in the study.

The integration of AI in breast cancer screening has the potential to revolutionize the way we detect and treat breast cancer, but it's essential to address the potential drawbacks and ensure that human oversight is maintained.